Clinical Trial

A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-631 in healthy adult volunteers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-07.
Status change: Not Yet Recruiting → Completed 2026-04-16
Trial Details
NCT Number NCT07069036
Lead Sponsor Septerna, Inc.
Conditions Healthy Volunteers
Enrollment 120 participants
Start Date 2025-07-15
Primary Completion 2025-12-18 (estimated)
Study Completion 2025-12-18 (estimated)
Updated on ClinicalTrials.gov 2026-04-21